Clinical Trial Update: Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports the completion of a study evaluating intravenously administered SNS-032 in patients with advanced B-cell malignancies, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• SNS-032

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: B-lymphoid Malignancies, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED